Stop looking for answers,
innovate with the right partner

Novel technologies, great startups and innovative business opportunities at one click. Meet brilliant experts worldwide.

Popular on Innoget


Seeking revolutionary plant protein sources

  • Read
  • Posted by PepsiCo
  • ·
  • Project Size : 250,000 - 1,000,000 €

PepsiCo seeks to incorporate new plant proteins into their world-class foods and beverages. Consumers are increasingly selecting products that feature plant-based proteins: from rice milk to pasta made from chickpeas. Additionally, market demand also indicates a continued strong interest in protein-rich foods. An unfortunate side-effect of high levels of plant protein in food products is that various organoleptic properties, such as color, taste and texture, can be negatively impacted which, in turn, degrades consumer acceptance of those products. As such, PepsiCo is interested in innovative plant proteins that have undergone some level of concentration. 
Researchers & organizations who have exciting new plant protein concentrates with the potential for commercial-scale implementation on suitable timelines are strongly encouraged to respond.

Covid-19 Innovation Challenges by Innoget

Seeking proposals to advance the knowledge on COVID-19 and on the coronavirus family

  • Read
  • Posted by Covid-19 Innovation Challenges by Innoget
  • ·
  • Project Size : Strategic project backed by large scale funding €

The current coronavirus (COVID-19) outbreak has been declared by WHO as a Public Health Emergency of International Concern according to the International Health Regulation. It is crucial to rapidly gain a better understanding of the newly identified virus, especially in relation to potential clinical and public health measures that can be put to immediate use to improve patients’ health and/or contain the spread of COVID-19. Collaboration of private companies, academia, international organisations, public bodies etc. has the potential to accelerate the development of therapeutics and diagnostics to tackle this current and future outbreaks. The actions resulting from this call will contribute to the pan-European efforts responding to this Public Health Emergency. Proposals submitted under this topic are expected to advance the knowledge specifically on COVID-19 and more widely on the coronavirus family with the aim of contributing to an efficient patient management and/or public health preparedness and response to current and future outbreaks of coronavirus infection.

Kim Mathias from The Procter & Gamble Company

Seeking insect control products and technologies that are non-toxic to people and pets, yet perform as well or better than their toxic counterparts.

  • Read
  • Posted by Kim Mathias from The Procter & Gamble Company
  • ·
  • Project Size : 50,000 - 250,000 €

The global home insecticide market is dominated by chemicals that are toxic to insects, people, and pets. P&G Ventures is interested in insect control products and technologies that are non-toxic to people and pets, yet perform as well or better than their toxic counterparts. P&G is interested in all segments of insect control (contact killer, barriers, traps, on-body repellents and foggers) and managing the following insects: House Flies, Mosquitoes, Fruit Flies, Stink Bugs, Bed Bugs, Roaches, Ants, Moths, Gnats, Spiders, Silverfish, Centipedes, Millipedes.

Universidad de Alicante

Wind flow Interface concentrator for VAWT

  • Read
  • Posted by Universidad de Alicante
  • ·
  • Patents for licensing

The researchers of the University have developed a wind flow concentrator incorporated into a Vertical Axe Wind (VAWT), which allows a significant increase in wind speed before being injected to the turbine. The system allows the optimization of the currents with independence of its direction and it is applicable to any type of VAWT. It is suitable for any type of building.

Fundació URV

New method for the diagnosis of cutaneous leishmaniasis

  • Read
  • Posted by Fundació URV
  • ·
  • Patents for licensing

Leishmaniasis is an endemic parasitic disease that is found in most parts of the tropics, subtropics and southern Europe. Cutaneous Leishmaniasis (CL) is the most common form of Leishmaniasis. It is caused by the protozoan Leishmania parasites, which are transmitted by the bite of infected female phlebotomine sand-flies. Cutaneous Leishmaniasis causes skin lesions, mainly ulcers, on exposed parts of the body, leaving life-long scars and serious disability. The skin lesions usually develop within several weeks or months after exposure. About 95% of Cutaneous Leishmaniasis cases occur in the Americas, the Mediterranean basin, the Middle East and Central Asia. An estimated number of 0.6 million to 1 million cases occur worldwide annually. Over two thirds of new Cutaneous Leishmaniasis cases occur in the next six countries: Afghanistan, Algeria, Brazil, Colombia, Iran and Syria. Cutaneous Leishmaniasis is diagnosed by detecting Leishmania parasites in tissue specimens from skin lesions via light-microscopic examination of stained slides, specialized culture techniques, or molecular methods. This disease is treatable and curable. Early diagnosis and effective case management reduces the prevalence of the disease and prevents disabilities and death. Hence, early detection and prompt treatment of cases would therefore help to reduce transmission and to monitor the spread and burden of the diseases. In this invention, a new system for non-invasive, early, fast and easy to use diagnosis test for Cutaneous Leishmaniasis from exhaled breath analysis has been developed.

Patrick Van De Vyver from Bainisha

High-definition respiratory monitoring tool - Bainisha's Twin Chest System

  • Read
  • Posted by Patrick Van De Vyver from Bainisha
  • ·
  • Innovative Products and Technologies

Current technology Current systems for measuring/monitoring respiratory movements (such as Thorax displacement) @ medical level, rely on one single technology: Inertial Measurement Units (IMU) aka "accelerometry". The resulting data of such measurements however are very often inadequate & hard or impossible to interpret. Problem E.g. the raw IMU-data output of coughing may look exactly the same as the raw IMU-data of riding a bike on really bumpy road ! When such type of confusion arises, it is impossible to distinguish between very different events. Solution A second sensor technology is added: a very thin, ultra-stretchable, very accurate displacement sensor. This sensor is fixed to the body as a simple self-adhesive patch. The fixation is of such a high quality and "integrates" with the skin so thoroughly, that it is nick-named a "Second Skin"-sensor. Together with the on-board IMU the "Second Skin" sensor forms a Sensor Fusion System. I.e. by cross-linking the raw data of two very different sensor concepts all uncertainties, "grey"-zones and impossible to interpret situations are eliminated. The sensor-fusion concept also widens and multiplies the capabilities for capturing a multitude of different types of "body language/events"

Job opportunities

Introducing Innoget Jobs

Great innovation projects are built with
talented and creative people.

Reach your candidate

Trusted at organizations large and small
Innoget is the most advanced innovation network to connect with decision makers interested in investing in you. It's free.

Free to join - no credit card required

How Innoget works

A trusted innovation network that will drive your project forward

Accelerate your innovation projects with a leading-edge innovation network that will put you in front of potential partners worldwide.

Read tailored updates

Read tailored updates

Find publications and meet experts to advance your projects. Follow and contact them in a leading-edge innovation network with experts from 180+ countries in all innovation disciplines.

Get in-depth stats

Get in-depth stats

See real-time stats on your innovation network activity. Build trust. Become a global innovation influencer.

Create exposure

Create exposure

Publish your posts to search for innovative solutions, present your novel technology, bring your startup to the innovation scene, publish your research outcome and much more.

Meet brilliant experts

Meet brilliant experts

Collaborate and chat with key innovation stakeholders in all business, technology and research areas.


Get ready to find the right partner in 30"

Invest 30" to start building your innovation network, get business opportunities, meet global partners and fast-track your innovation projects.


Sign up. It's free.

Sign in and complete your professional profile to match you with the right publications, partners and opportunities.


Meet brilliant partners

Novel technologies, great startups and innovative business opportunities at one click. Meet brilliant experts worldwide.


Connect and chat

Find colleagues connected to your innovation and research areas. Chat, follow them and build your innovation network.

This might help you

Frequently Asked Questions

Some queries you might have before joining Innoget, the trusted innovation network.

Is Innoget free to join?

Yes. You can sign up completely free with a free Basic account. No credit card required.

Can I operate on Innoget for free?

Yes, you can.

Have more questions? Drop us an email. One of our success managers will be back to you soon.

How many publications can I post?

You can publish unlimited publications for free.

Can I manage my privacy?

Yes. You can hide or unhide your profile and allow or prevent people from following you.